AstraZeneca ' s Tagrisso Helps Lung Cancer Patients Live Longer- Study AstraZeneca ' s Tagrisso Helps Lung Cancer Patients Live Longer- Study

AstraZeneca Plc said on Friday a late-stage study showed its top-selling drug, Tagrisso (osimertinib), had significantly helped patients with a type of lung cancer live longer without the disease worsening.Reuters Health Information
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Hematology-Oncology News Source Type: news